Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating non-small-cell lung cancer using pharmaceutical formulation containing thienotriazolodiazepine compounds

Method of treating non-small-cell lung cancer using pharmaceutical formulation containing thienotriazolodiazepine compounds

US Patent 9820992 · Granted Nov 21, 2017

Estimated economic value: $40,479,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of treating acute myeloid leukemia and/or acute lymphoblastic leukemia us2018
Method of treating non-small cell lung cancer and/or small cell lung cancer usin2018
Method of treating non-small cell lung cancer and/or small cell lung cancer usin2018
Method of treating leukemia using pharmaceutical formulation containing thienotr2017
Method of treating leukemia using pharmaceutical formulation containing thienotr2017
Treatment of cancers2009
System and method for invoice confirmation and funding2008